Market Place
Sourcing Support
Moberg Pharma Lowers Expectations For Phase 3 Trial Primary Endpoint
13 Sep 2024 //
PR NEWSWIRE
Moberg Pharma Secures Warrant Exercise And Top Guarantee
11 Jun 2024 //
PR NEWSWIRE
Terclara is the market leader in Sweden
21 May 2024 //
PHARMIWEB
National approval for MOB-015 in all 13 countries
07 May 2024 //
PHARMIWEB
Moberg Pharma´s interim report January - March 2024
07 May 2024 //
PHARMIWEB
Moberg has completed enrollment to Phase 3 study for MOB-015 in North America
06 Oct 2023 //
PR NEWSWIRE
Moberg Pharma and Padagis sign agreement for MOB-015 in Israel
04 Aug 2022 //
PRNEWSWIRE
Moberg Pharma enters into collaboration with Allderma for launch in Scandinavia
08 Nov 2021 //
PRNEWSWIRE
Moberg Pharma receives approval from the EMA`s Paediatric Committee
22 Sep 2021 //
PRNEWSWIRE
Moberg Pharma intends to distribute and separately list BupiZenge® (BUPI)
06 Nov 2020 //
PRNEWSWIRE
Moberg decides on fully guaranteed rights issue of approximately SEK 150M
06 Nov 2020 //
PRNEWSWIRE
Moberg Pharma decides on fully guaranteed rights issue of approximately SEK 150m
05 Nov 2020 //
PRESSRELEASE
Moberg Pharma intends to submit a registration application in Europe in 2021
14 Oct 2020 //
PRNEWSWIRE
Moberg Pharma Meets Primary Endpoint in the European Phase 3 Study
24 Jun 2020 //
PRNEWSWIRE
Expert Evaluation Clarifies Phase 3 Results for MOB-015
20 Jan 2020 //
PR NEWSWIRE
Moberg Pharma ph3 study of MOB-015 to treat onychomycosis meets primary endpoint
09 Dec 2019 //
PHARMABIZ
Moberg Pharma and Taisho Sign Exclusive License Agreement for MOB-015 in Japan
30 Sep 2019 //
BIOSPACE
Moberg Pharma Completes the Divestment of the OTC-business for USD 155 million
29 Mar 2019 //
PR NEWSWIRE
Moberg Pharma Divests OTC-business & Secures New Funding for MOB-015
11 Feb 2019 //
PR NEWSWIRE
Moberg Pharma inks pact with Randob Labs to divest Balmex for $4.25 million
28 Feb 2018 //
PHARMABIZ
Moberg Pharma Receives Favorable Outcome From NAD - Main Competiton
15 Jan 2018 //
PR NEWSWIRE
Strides to acquire PediaCare from Moberg Pharma
28 Nov 2016 //
BIOSPECTRUM
Moberg Pharma Receives European Patent for BUPI to Treat Oral Mucositis
22 Oct 2016 //
PHARMABIZ
Moberg Pharma agrees to acquire three US OTC brands from Prestige Brands
01 Jul 2016 //
PBR
Strides Shasun acquires 3 brands of Moberg Pharma
05 Apr 2016 //
ECONOMIC TIMES
Strides Shasun to acquire three brands of Moberg Pharma for $10 million
08 Mar 2016 //
ECONOMIC TIMES
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.